Skip to main content
. 2019 Dec 23;23(1):74–81. doi: 10.1089/jpm.2018.0646

Table 2.

Comparison Between Patients Receiving Prolonged Mechanical Ventilation Treated With and Without Maintenance Dialysis Stratified by Clinical Factors

Clinical factors No. of patients (%)
p*
With MD Without MD
Total 1035 (3.4%) 29,524 (96.6%)  
Survival rate
 >30 Days 67.6% 75.3%  
 >91 Days 40.8% 55.3%  
 >182 Days 24.1% 44.5%  
 >365 Days 12.6% 34.4%  
 Censored 12.1% 26.8%  
Life expectancy (days, 95% CI) 265 (249–281) 723 (716–731) <0.0001
Gender female (%) 545 (52.7) 11,711 (39.7) <0.0001
Age (years)     <0.0001
 ≤60 218 (21.1%) 5258 (17.8%)  
 60–70 278 (26.9%) 4559 (15.4%)  
 70–80 392 (37.9%) 10,101 (34.2%)  
 >80 147 (14.2%) 9606 (32.5%)  
Hospital size
 Medical center, N (%) 440 (42.5) 11,013 (37.3) 0.0007
Chronic comorbidities, N (%)
 DM 355 (34.3) 5779 (19.6) <0.0001
 HTN 318 (30.7) 4008 (13.6) <0.0001
 COPD 36 (3.5) 4907 (16.6) <0.0001
 Cancer 61 (5.9) 3669 (12.4) <0.0001
  Urological cancera 15 (1.4) 130 (0.4) <0.0001
 Hydrocephalus 26 (2.5) 969 (3.3) 0.1701
 Cirrhosis 26 (2.5) 800 (2.7) 0.7000
Acute comorbidities, N (%)
 Pneumonia 399 (38.6) 14,155 (47.9) <0.0001
 Septicemia 319 (30.8) 7091 (24.0) <0.0001
 Shock 190 (18.4) 3662 (12.4) <0.0001
 Gangrene 11 (1.1) 225 (0.8) 0.2774
 Peritonitis 32 (3.1) 447 (1.5) <0.0001
 Device complications 64 (6.2) 211 (0.7) <0.0001
a

Urinary bladder or kidney cancer (ICD-9: 188 malignant neoplasm of bladder, 189 malignant neoplasm of kidney and other unspecified urinary organs).

*

p-Value refers to the comparison between patients receiving PMV treated with and without MD, using the chi-square test.

CI, confidence interval; MD, maintenance dialysis; PMV, prolonged mechanical ventilation.